Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,231 | -8,709 | -4,789 | -3,408 | -1,671 |
| Depreciation Amortization | 1 | 2,479 | 248 | 168 | 84 |
| Accounts receivable | N/A | 1 | 1 | N/A | N/A |
| Other Working Capital | 201 | 763 | 165 | 247 | -431 |
| Other Operating Activity | 156 | 1,072 | 911 | 690 | 365 |
| Operating Cash Flow | $-874 | $-4,395 | $-3,463 | $-2,303 | $-1,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -3 | -3 | -1 | -1 |
| Investing Cash Flow | $N/A | $-3 | $-3 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,659 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 2,117 | 2,114 | N/A | N/A |
| Other Financing Activity | 0 | 18 | 18 | 0 | 0 |
| Financing Cash Flow | $1,659 | $2,135 | $2,132 | $N/A | $N/A |
| Exchange Rate Effect | -1 | -5 | 1 | -1 | -1 |
| Beginning Cash Position | 1,422 | 3,747 | 3,732 | 3,815 | 3,846 |
| End Cash Position | 2,206 | 1,480 | 2,399 | 1,512 | 2,192 |
| Net Cash Flow | $784 | $-2,267 | $-1,334 | $-2,303 | $-1,655 |
| Free Cash Flow | |||||
| Operating Cash Flow | -874 | -4,395 | -3,463 | -2,303 | -1,653 |
| Capital Expenditure | N/A | -3 | -3 | -1 | -1 |
| Free Cash Flow | -874 | -4,397 | -3,466 | -2,304 | -1,654 |